There is no single best SCE Medical Oncology resource — only the right one for your domain profile, your weeks to the exam and your budget. This decision tree helps higher specialty trainees choose a primary question bank, official calibration and, where needed, a teaching layer, and it flags two oncology-specific traps: one major UK vendor does not cover this SCE at all, and a well-known "oncology exam" bank is built for a different, European assessment. iatroX sits here as the cross-specialty knowledge and unseen-MCQ layer — not a specialty oncology bank.
What you are actually revising for
The Specialty Certificate Examination (SCE) in Medical Oncology, run by the Federation of the Royal Colleges of Physicians (MRCP(UK)), has a fixed structure: two papers of 100 best-of-five (BOF) questions, 200 in total, each paper three hours, sat on one day at a computer-based test centre (Surpass). One mark per correct answer, no negative marking. It runs once a year, currently in September. There is no formal entry requirement, but UK trainees usually sit it in the penultimate year of higher specialty training.
The blueprint is drawn from the JRCPTB Specialty Training Curriculum for Medical Oncology and spans the whole syllabus: the site-specific malignancies (breast, thoracic, gastrointestinal, genitourinary, gynaecological, head and neck, central nervous system, skin and melanoma, sarcoma and cancer of unknown primary), systemic anti-cancer therapy (cytotoxics, immunotherapy, targeted and biological agents and endocrine therapy), the management of treatment toxicity, oncological emergencies, palliative and supportive care, cancer biology and genetics, the principles of radiotherapy and surgery, and clinical trials, statistics and research methodology. Confirm the current sitting date and blueprint document on thefederation.uk before you plan. The systemic-therapy and toxicity content is high-yield and moves quickly, so currency of your source matters more here than in slower-moving specialties.
Two oncology-specific traps before you spend
Not every UK SCE vendor covers oncology. BMJ OnExamination publishes several SCE banks — as of 21 July 2026 its catalogue includes Acute Medicine, Endocrinology and Diabetes, Geriatric Medicine, Respiratory Medicine and Neurology — but it does not offer an SCE Medical Oncology bank. Do not assume a familiar vendor carries your specialty; verify coverage before subscribing.
The ESMO Examination is a different exam. The European Society for Medical Oncology runs its own Examination for Medical Oncologists, a separate European knowledge certification that is not the UK SCE. Banks written for the ESMO exam overlap in clinical content but are not mapped to the UK SCE blueprint, so treat them as supplementary reading, never as your primary UK-SCE resource.
Choose by learner profile, not by brand
Advice that names a product before it asks about you fails candidates. A registrar fresh off a breast-and-lung rotation and a trainee returning from lab research have different gaps, and the same bank is right for one and wrong for the other. Segment yourself first, define the smallest stack that closes your gaps, then map named resources to the jobs they do well.
Segment yourself first
Place yourself in one of six profiles — a blend of two is normal:
- First attempt, adequate runway. You need even coverage across many tumour sites plus the non-site content (statistics, trials, biology), and calibration — not sheer volume.
- Retake. You have feedback on the domains and question types that cost you marks; your work is targeted.
- Busy trainee revising around clinics. Time is the constraint; you need short, resumable blocks.
- Weak foundations. You need a teaching or reference layer before high-volume MCQs, often in cancer biology, genetics or statistics.
- Strong knowledge, poor pacing. You need timed, mixed, full-length practice, not more content.
- Strong on isolated facts, weak on applied reasoning. You recall regimens but miss the integrated "next best step" — sequencing therapy, managing toxicity, reading a trial — and need harder stems and worked reasoning.
The minimum effective stack
For almost every candidate the minimum effective stack is four items, often fewer:
- One primary question bank, worked to completion with your errors logged.
- Official calibration — the Federation's published SCE Medical Oncology sample questions — to anchor your practice to the real paper's style and standard.
- One teaching or reference source where a domain is genuinely weak — a dedicated SCE SBA text, a specialty guideline, or focused reading on trials and statistics.
- One modality tool where needed — staging and imaging practice, or a statistics and trial-appraisal drill for the research-methodology items. Skip it if that is a strength.
Adding banks reflexively duplicates questions and corrupts your calibration; the Two-Q-Bank Rule explains how to add a second source only when a measured gap justifies it.
Budget bands — verify every price on the day you buy
Treat these as structure, not figures; confirm current costs on each vendor's page (checked 21 July 2026, figures not reproduced here).
- Free / low-cost. The Federation's official Medical Oncology sample questions are free and are your calibration gold standard. iatroX's free UK-core banks provide unseen cross-specialty items and a measurement baseline at no cost. A borrowed SBA text completes a workable low-cost stack.
- One premium resource. A single SCE-specialised oncology bank, finished properly. StudyPRN publishes a dedicated SCE Medical Oncology bank; a specialist provider such as License-Medical is a further option — verify current coverage and price for each.
- Comprehensive stack. A premium bank, a dedicated SCE SBA oncology text, guideline and trial reading, and iatroX for unseen measurement. Worth it only if you have the weeks to use all of it.
Time bands — decide what to cut, not what to add
- Under four weeks. One bank, subject-mixed and timed, plus the official questions in the final week. Prioritise the high-yield systemic-therapy, toxicity and common-tumour-site content; cut the second bank.
- Four to twelve weeks. One bank worked to completion, a teaching layer for one or two weak domains (often statistics or the rarer sites), and official calibration in the final fortnight.
- More than twelve weeks. Add breadth and retention: spaced repetition for regimens and biomarkers, cross-specialty MCQ practice for the general-medicine overlap, and a mid-point unseen check. Finish on official and unseen items.
The decision matrix — resources mapped to their best job
Match a resource to the job it does best, then let your profile and time band choose the row. Verify all product facts and prices (as of 21 July 2026).
| Resource | Best job | Choose it when | Verify / caveat |
|---|---|---|---|
| Federation SCE Medical Oncology sample questions | Official calibration of tone and difficulty | Always — every candidate | Free; finite set; on thefederation.uk |
| StudyPRN SCE Medical Oncology | High-volume specialty coverage and analytics | You want a dedicated SCE bank with breadth | Vendor-reported count/price; confirm on studyprn.com |
| License-Medical (oncology) | Alternative specialty bank | You want a second SCE-oriented source | Verify it covers the UK SCE and its price |
| SCE SBA oncology text | Teaching and portable revision | You prefer worked SBAs on paper | A text, not an adaptive bank |
| ESMO-exam bank | Supplementary content reading only | You have covered the UK-SCE material | A different, European exam — not mapped to the UK SCE |
| BMJ OnExamination | Does not cover this SCE | — | No SCE Medical Oncology bank as of 21 July 2026 |
| iatroX | Cross-specialty knowledge + unseen-MCQ measurement | You need an independent readiness signal | Not a specialty oncology bank |
This article is the exam-level hub for "which resource?"; the narrow audits carry the detail, and you can line the products up in the iatroX comparison hub rather than repeating them here.
Three worked candidate profiles
Leah — first attempt, twelve weeks, strong solid tumours, weak statistics and trials. Her stack: one premium SCE oncology bank plus the official questions, with a focused trials-and-statistics teaching layer. Weekly: four subject-mixed blocks of 30 items, one dedicated statistics-and-trials block, and every second Sunday an unseen iatroX block to confirm her weak domain is improving on novel questions. Exit criterion: unseen statistics accuracy within ten points of her overall, and a full timed paper finished on time.
Marcus — retake, six weeks, knowledge fine but weak on toxicity management and pacing. No new bank. Marcus works timed and full-length: two 100-question sessions a week, reviewing only flagged and wrong items, with a hard under-90-seconds rule and a dedicated pass over immunotherapy and chemotherapy toxicity. Official questions in the final week; timed iatroX unseen blocks confirm the fix holds under novelty. Exit criterion: two consecutive full papers finished inside three hours above the standard-setting range.
Sara — busy trainee, eight weeks around clinics, patchy on rarer sites. A small stack: one bank in 15-minute blocks, guideline reading for sarcoma, cancer of unknown primary and CNS tumours, and a spaced-repetition deck for staging she keeps dropping. She protects short blocks on clinic days and longer ones off. iatroX free blocks give the unseen check a memorised bank cannot. Exit criterion: no tumour-site domain more than fifteen points below her mean on unseen items.
The evidence hierarchy behind these recommendations
Rank your sources. Official material comes first for format and standard — the Federation defines the paper, so its sample questions are the calibration gold standard. Primary guidance comes first for content — NICE, the relevant specialty-society guidance (including ESMO and UK guidance) and, for systemic anti-cancer therapy, the SmPC via the electronic medicines compendium (eMC). Vendor pages are for product facts, treated as vendor-reported and date-checked. Independent testing — your own results and peer reports — is for user experience. Never invert this: a vendor's marketing figure is not a clinical fact, and your Q-bank percentage is not your exam score.
Three mistakes this decision tree is designed to stop
First, assuming your usual SCE vendor covers oncology — several do not, so verify before you pay. Second, revising on an ESMO-exam bank as though it were the UK SCE; the content overlaps but the blueprint does not. Third, treating a memorised bank as a readiness signal — always finish on official and unseen items.
The bottom line
Pick your profile, build the smallest stack that closes your specific gaps, and let your weeks-to-exam decide what to cut — after checking that the resource actually covers the UK SCE and not a different exam. One finished specialty bank, the official questions and an honest unseen check beat a shelf of half-worked resources. Use iatroX for the unseen, cross-specialty signal that tells you which branch of this tree you are on, then act on the gap.
Frequently asked questions
How do I know whether I have covered the full SCE Medical Oncology blueprint? Map your practice against the JRCPTB curriculum domains — every tumour site plus the non-site content (systemic therapy, toxicity, emergencies, palliative care, biology and genetics, trials and statistics) — rather than your bank's internal categories, because a bank can look complete while under-representing rarer sites or the statistics load. Build a simple blueprint-coverage matrix with each domain down one axis and questions attempted and accuracy across the other. The Federation's blueprint and sample questions define the real target; completing a commercial bank is not the same as covering the curriculum.
Can one question bank be enough for SCE Medical Oncology? For many well-prepared candidates, yes — one dedicated SCE oncology bank worked to completion, combined with the official sample questions and an honest unseen check, is a defensible stack. Because BMJ OnExamination does not cover this SCE, your realistic dedicated-bank choices are narrower than in other specialties, which makes finishing your chosen bank properly more important than owning several. Add a second source only for a measured, domain-specific gap, not for reassurance.
What should I measure instead of my overall Q-bank percentage for SCE Medical Oncology? Measure per-domain accuracy on unseen questions, accuracy under strict timing, and the trend of both — not a single headline percentage inflated by repeated exposure. A strong overall can hide weak statistics or a neglected tumour site that will cost you across a whole blueprint domain. Your Q-bank percentage is not your exam score; the signals that predict readiness are domain balance, timed performance and improvement on genuinely novel items.
When should I stop doing new SCE Medical Oncology questions? Stop adding brand-new questions when your unseen, timed accuracy has plateaued across domains and your remaining errors are careless rather than knowledge gaps — usually the final few days. New volume then adds fatigue, not learning; switch to reviewing your error log, consolidating high-yield regimens, biomarkers and toxicity rules, and rehearsing pacing across the two three-hour papers. The final stretch is for retrieval and calibration, not for chasing more items.
Which SCE Medical Oncology resource should I use for my weakest component? Match the resource to the type of weakness, not the topic label. If the weakness is knowledge — a rarer tumour site, cancer biology or statistics — use a teaching or reference layer first (a guideline, an SBA text chapter, a statistics primer), then targeted question blocks. If it is application — you know the regimens but miss the sequencing or toxicity-management item — use harder integrated stems and worked reasoning, such as the Socratic Tutor in iatroX on your missed items. Diagnose knowledge versus application before you spend.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 21 July 2026. Question counts, prices and product features attributed to third-party platforms are vendor-reported and current as of that date; verify them on the vendor's own page before purchase. Two findings are stated plainly and were checked on that date: BMJ OnExamination does not offer an SCE Medical Oncology bank, and the ESMO Examination is a separate European assessment, not the UK SCE. Disclosure: iatroX operates a UK question bank and clinical-knowledge platform and competes with some products named here; its role is confined to cross-specialty knowledge and unseen-question measurement — it is not a specialty-specific SCE Medical Oncology bank, and where a dedicated specialty bank is the better tool, this article says so. Corrections are welcome via the feedback route on iatrox.com.
References: Federation of the Royal Colleges of Physicians (MRCP(UK)) — SCE in Medical Oncology exam page, sample questions and blueprint (thefederation.uk); JRCPTB Specialty Training Curriculum for Medical Oncology; StudyPRN SCE Medical Oncology product page and License-Medical oncology bank (vendor-reported); European Society for Medical Oncology — ESMO Examination for Medical Oncologists (esmo.org, a separate exam); a dedicated SCE Medical Oncology SBA reference text; iatroX — Your Q-Bank Percentage Is Not Your Exam Score; iatroX blueprint-coverage matrix and Two-Q-Bank Rule articles; iatroX comparison hub (iatrox.com/compare).